Cargando…

Seropositivity for SARS-CoV-2 in a General Population: How Specific Is the Diagnostic?

Detalles Bibliográficos
Autores principales:	Lyu, Zhaoqing, Fujitani, Tomoko, Harada, Kouji H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Epidemiological Association 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727207/ https://www.ncbi.nlm.nih.gov/pubmed/35908935 http://dx.doi.org/10.2188/jea.JE20220151

Ejemplares similares

Serological Tests for SARS-CoV-2 Coronavirus by Commercially Available Point-of-Care and Laboratory Diagnostics in Pre-COVID-19 Samples in Japan
por: Lyu, Zhaoqing, et al.
Publicado: (2020)

Insufficient Number of Controls for Low SARS-CoV-2 Seroprevalence: Are the Positive Rates Statistically Different between Pre-pandemic and Post-pandemic Samples?
por: Fujitani, Tomoko, et al.
Publicado: (2022)

SARS CoV-2 seropositivity in haemodialysis patients
por: Toapanta, Nestor, et al.
Publicado: (2022)

Letter to the editor regarding “spatiotemporal association of low birth weight with Cs-137 deposition at the prefecture level in Japan after the Fukushima nuclear power plant accidents”
por: Soleman, Sani Rachman, et al.
Publicado: (2020)

Association between urinary zinc excretion and isoflavone-metabolizing enterotypes among Japanese females: a cross-sectional study
por: Fujitani, Tomoko, et al.
Publicado: (2023)

Large increases in SARS-CoV-2 seropositivity in children in England: Effects of the delta wave and vaccination
por: Oeser, Clarissa, et al.
Publicado: (2022)

Urinary equol levels are positively associated with urinary estradiol excretion in women
por: Fujitani, Tomoko, et al.
Publicado: (2021)

Association between lignan polyphenol bioavailability and enterotypes of isoflavone metabolism: A cross-sectional analysis
por: Fujitani, Tomoko, et al.
Publicado: (2023)

Seropositivity and risk factors for SARS-CoV-2 infection in staff working in care homes during the COVID-19 pandemic
por: Rowland, Thomas A.J., et al.
Publicado: (2021)

Solidifying diagnostics in SARS-CoV-2 research
por: Cimolai, Nevio
Publicado: (2022)

How Does SARS-CoV-2 Fragment the QRS?
por: Finsterer, Josef
Publicado: (2022)

Development of a protective device for RT-PCR testing SARS-CoV-2 in COVID-19 patients
por: Tsuchida, Tomoya, et al.
Publicado: (2020)

Seropositive Prevalence of Antibodies Against SARS-CoV-2 in Wuhan, China
por: Liu, Anding, et al.
Publicado: (2020)

Persistence of infection-induced SARS-CoV-2 seropositivity throughout gestation
por: Staszewski, Cara, et al.
Publicado: (2022)

Chlorinated persistent organic pollutants in human breast milk in the Miyagi Prefecture disaster-affected area 1 year after the Great East Japan Earthquake of 2011
por: Choi, Jungmi, et al.
Publicado: (2023)

SARS-CoV-2 diagnostic testing in Africa: needs and challenges
por: Adebisi, Yusuff Adebayo, et al.
Publicado: (2020)

Strengths and weaknesses of the diagnostic tests for SARS-CoV-2 infection()
por: Hernández-Pérez, José María, et al.
Publicado: (2020)

From Molière to SARS-CoV-2: How Medicine has changed
por: Perciaccante, A., et al.
Publicado: (2022)

Profile of specific antibodies to SARS-CoV-2: The first report
por: Xiao, Ai Tang, et al.
Publicado: (2020)

Parenteral nutrition in oxygen escalation/de-escalation in SARS-CoV. When and how?
por: Quintero O, Oscar Iván, et al.
Publicado: (2022)

High mortality of cancer patients in times of SARS-CoV-2: Do not generalize!
por: van Dam, Peter A., et al.
Publicado: (2020)

SARS-CoV-2: “Three-steps” infection model and CSF diagnostic implication
por: Panciani, Pier Paolo, et al.
Publicado: (2020)

Realistic considerations for comparison between SARS-CoV-2 molecular diagnostic assays
por: Poon, Kok-Siong, et al.
Publicado: (2021)

Effect of varying storage conditions on diagnostic test outcomes of SARS-CoV-2
por: Oguri, Satoshi, et al.
Publicado: (2021)

Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
por: Moran, Angelica, et al.
Publicado: (2020)

Re: Profile of specific antibodies to SARS-CoV-2: The first report
por: Zeng, Zhikun, et al.
Publicado: (2020)

Absence of Detectable Radionuclides in Breast Milk in Sendai, Japan in 2012 Even by High-Sensitivity Determination: Estimated Dose among Infants after the Fukushima Nuclear Disaster
por: Lyu, Zhaoqing, et al.
Publicado: (2021)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
por: Xia, Yong, et al.
Publicado: (2020)

Safety considerations for the use of Point‐Of‐Care diagnostics during SARS‐CoV‐2 pandemic
por: Raimann, Florian J., et al.
Publicado: (2020)

Applications of clear Dx whole genome sequencing system in SARS-CoV-2 diagnostics
por: Abdullah, Khansaa, et al.
Publicado: (2022)

SARS-CoV-2 and dentistry
por: Ortega, Karem L., et al.
Publicado: (2020)

SARS-CoV-2 in cardiomyocytes
por: Finsterer, Josef
Publicado: (2021)

Pharmacotherapeutics of SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2022)

Adverse reactions of drugs specifically used for treatment of SARS-CoV-2 infection
por: Tang, Mi, et al.
Publicado: (2021)

Adverse reactions of drugs specifically used for treatment of SARS-CoV-2 infection
por: Tang, Mi, et al.
Publicado: (2021)

Seropositivity for Brucellosis in Veterinarians
por: Patil, Niranjan B, et al.
Publicado: (2013)

Asymptomatic SARS-CoV-2 infection and CT lung lesions: how reliable is the hypothesised association?
por: Scordato, Davide
Publicado: (2021)

SARS-CoV-2: a general recommendation to adhere to government regulations cannot be evidence-based
por: Kampf, G., et al.
Publicado: (2021)

Evaluation of a Rapid Diagnostic Assay for Detection of SARS-CoV-2 Antigen in Nasopharyngeal Swabs
por: Lambert-Niclot, Sidonie, et al.
Publicado: (2020)

Diagnostic testing for SARS-CoV-2 infection in HHT patients: nasopharyngeal versus oropharyngeal swab
por: Pagella, Fabio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c592l4gq491ihh25t5mdlfduck